scispace - formally typeset
J

James J. Collins

Researcher at Massachusetts Institute of Technology

Publications -  700
Citations -  105255

James J. Collins is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Synthetic biology & Population. The author has an hindex of 151, co-authored 669 publications receiving 89476 citations. Previous affiliations of James J. Collins include Baylor College of Medicine & University at Albany, SUNY.

Papers
More filters

Systems biology promises to personalize medicine via network-based biomarkers that predict therapeutic effectiveness. Toward this goal, Chang et al. (2009) recently introduced a systems-based approach to break down oncogenic signaling networks into modules that predict the effectiveness of pathway-specific therapeutics.

TL;DR: A method to dissect signal transduction pathways into individual signaling modules, based on gene expression profiles, is devised, which identifies a set of genes likely impacted by alterations to a given signaling pathway.
Book ChapterDOI

Reverse engineering gene regulatory networks

TL;DR: The approaches discussed aim to gain insights into the logic of combinatorial regulation occurring at a gene promoter, the activity of regulatory factors distinct from their abundance, the identification of key regulators in a gene network, and the prediction of drug compound mode of action.
Patent

Sensitization of bacterial cells to quinolone antibiotics

TL;DR: In this article, pharmaceutical compositions and kits for sensitizing a microorganism or a population of microorganisms to a quinolone antibiotic are presented, which are useful in treating infections resulting from high density bacterial cultures, such as pneumonia, genitourinary infections, biofilms, prosthetic graft infections, sepsis, and endovascular infections.
Patent

Inhibiteurs reca à activité antibiotique, compositions et méthodes d'utilisation

TL;DR: The authors concerne l'utilisation d'inhibiteurs RecA comme agents antibiotiques, and permet d'obtenir des inhibiteur RecA utiles for traiter des infections.